Increase Success Rate in Cancer Drug Trials: Medic Life Sciences [Genomics Startups #5]

17 feb 2021 · 15 min. 48 sec.
Increase Success Rate in Cancer Drug Trials: Medic Life Sciences [Genomics Startups #5]
Descrizione

Their mission is to make cancer drugs survive and resurrect from devastated clinical trials in which 93% of cancer drugs are failed. They have a proprietary technology that can produce...

mostra di più
Their mission is to make cancer drugs survive and resurrect from devastated clinical trials in which 93% of cancer drugs are failed. They have a proprietary technology that can produce 2 million different tumor samples to test pre-clinical cancer drugs. This technique is based on generating massive 3D organoids and whole-genome editing of cancer organoids by CRISPR.

*

This is a special "limited series" of 6 episodes focusing on genomics startups. In partnership with the Illumina Accelerator based in Cambridge and SF Bay Area, we have interviewed six genomics, life-sciences, and biotech startups, 2 in the UK and 4 in the US.

We will be following a 5-step Heroes' Journey structure for these startups. In each video, you can see the marked chapters at the bottom of the screen.

Getting to know our heroes,
Hear the "starting-up" story,
Paths crossing with the accelerator,
Toughest decisions they had to make,
Big learning moments and the future direction.

*

https://twitter.com/startupsoflndn
https://www.linkedin.com/company/startupsoflondon
https://www.instagram.com/startupsoflndn/
mostra meno
Informazioni
Autore SOL Labs
Sito -
Tag

Sembra che non tu non abbia alcun episodio attivo

Sfoglia il catalogo di Spreaker per scoprire nuovi contenuti

Corrente

Copertina del podcast

Sembra che non ci sia nessun episodio nella tua coda

Sfoglia il catalogo di Spreaker per scoprire nuovi contenuti

Successivo

Copertina dell'episodio Copertina dell'episodio

Che silenzio che c’è...

È tempo di scoprire nuovi episodi!

Scopri
La tua Libreria
Cerca